Skip to content
My WebMD Sign In, Sign Up

Multiple Sclerosis Health Center

Font Size

Don't Delay MS Treatment

Brain Creates New Lesions When Drug Therapy Delayed
By
WebMD Health News

Oct. 25, 2002 -- For people with multiple sclerosis (MS), a delay in treatment allows the disease to worsen.

A new study looks at treatment for relapsing-remitting MS, a form of the neurological disorder that involves acute attacks followed by recovery periods.

Those patients who didn't start drug therapy immediately -- who waited nine months after diagnosis -- accumulated new lesions in their brains, writes researcher Jerry S. Wolinsky, MD, director of the MS Research Group at the University of Texas Health Sciences Center in Houston.

His study appears in this month's edition of Neurology.

In his 18-month study, Wolinsky randomly assigned 224 MS patients to receive either the drug Copaxone or a placebo soon after diagnosis for the following nine months. Then all patients were given the active drug for the next nine months.

Teva Pharmaceuticals, the makers of Copaxone, supported this work.

"Over the entire 18 months of the study there were 35% fewer enhancing lesions among the patients who started drug therapy early," he says in a news release.

His study also finds that the group of patients receiving drug therapy continuously had 23% fewer relapses compared with the group who started active treatment nine months later. -->

Today on WebMD

brain and teriflunomide molecule
ARTICLE
neural fiber
ARTICLE
 
white blood cells
VIDEO
linguini with asparagus and mushrooms
ARTICLE
 
brain scan
ARTICLE
worried woman
ARTICLE
 
person writin in a notebook
ARTICLE
couple embracing
ARTICLE
 
man with cane
SLIDESHOW
skull and neck xray
ARTICLE
 
Stressed man
ARTICLE
doctor feeling patients neck
ASSESSMENT